HTFL HTFL AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss

AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss at other companies

MedtronicMDT

——

Edwards LifesciencesEW

——

Other financials

Income statement

See full

Revenue$52.6M+41.3%

Gross profit$42.2M+50.9%

Operating income-$29.5M-68.6%

Net income-$27.4M+15.4%

EPS (diluted)-$0.32+93.9%

Balance sheet

See full

Cash & equivalents$24.4M-78.7%

Total debt$26.3M—

Total equity$285.7M+132%

Total assets$344.0M—

Cash flow

See full

Operating cash flow-$30.1M-129%

CapEx$1.9M+71.6%

Free cash flow-$32.0M-124%

Valuation

See full

Market cap$2.97B—

Enterprise value$2.98B—

P/S15.5×—

Profitability

See full

Gross margin78.1%+2.4pp

Operating margin-39.7%-4.8pp

Net margin-58.4%-12.1pp

FCF margin-40.1%-2.4pp

Returns & leverage

See full

Return on equity37.1%—

Debt / equity0.1×—

Current ratio5.6×—

Where this comes from

Reported directly by HTFL in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.

The official record: HTFL’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about HTFL's afs and trading securities - unrealized loss position (>=12 months) accumulated loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is HTFL's AFS and trading securities - unrealized loss position (>=12 months) accumulated loss?: HTFL (HTFL) reported AFS and trading securities - unrealized loss position (>=12 months) accumulated loss of $0 in Q1 2026.